路易体障碍中tau病理的认知与病理影响
OBJECTIVE: To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co-occurring Alzheimer disease (AD) pathology impacts the anatomic distribution of α-synuclein (SYN) pathology and that co-occurring neocor…
要点
- 合并AD病理的LBD患者新皮质SYN负荷显著高于无AD病理者。
- LBD痴呆患者tau负荷与生前认知测试成绩呈负相关。
- LBD合并AD的tau分布以颞叶新皮质为主,不同于纯AD的额叶为主。
核心结论
- 合并AD病理的LBD患者新皮质SYN病理更重,tau病理与认知表现相关且分布可能不同于纯AD,tau共病理独特贡献于LBD认知障碍异质性。
研究设计与样本
- LBD患者分为合并中/重度AD共病理组(SYN+AD,n=20)和少/无AD共病理组(SYN-AD,n=35)。
- 采用数字组织学测量新皮质和皮质下/边缘区tau、β-淀粉样蛋白(Aβ)和SYN病理,并与生前认知测试关联。
主要发现
- SYN+AD组各新皮质区域SYN负荷均高于SYN-AD组(F1,54=5.6-6.0,p<0.02),但内嗅皮质和壳核无差异(F1,43-49=0.7-1.7,p>0.2)。
- SYN+AD组在颞叶介导的命名任务上表现差于SYN-AD组(t27=2.1,p=0.04)。
- 生前认知测试成绩与tau负荷呈负相关(r=-0.39至-0.68,p<0.05)。
- AD组各区域tau均高于SYN+AD组(F1,43=12.8-97.2,p<0.001);SYN+AD组颞叶新皮质tau比例高于AD组(t41=2.0,p<0.05),AD组额叶新皮质tau比例高于SYN+AD组(t41=3.3,p<0.002)。
- SYN+AD组与AD组新皮质Aβ严重程度和分布相似(F1,40-43=1.6-2.0,p>0.1)。
关键数值与推荐
- LBD合并AD共病理者新皮质SYN负荷更高,tau负荷与认知负相关,tau分布以颞叶新皮质为主而非额叶。
临床怎么用
- 在LBD痴呆患者中应关注合并AD病理的可能,tau共病理可能解释认知障碍异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co-occurring Alzheimer disease (AD) pathology impacts the anatomic distribution of α-synuclein (SYN) pathology and that co-occurring neocortical tau pathology in LBDs associates with worse cognitive performance and occurs in a pattern differing from AD. METHODS: Fifty-five autopsy-confirmed LBD (Parkinson disease with dementia, n = 36; dementia with Lewy bodies, n = 19) patients and 25 AD patients were studied. LBD patients were categorized as having moderate/severe AD copathology (SYN + AD = 20) or little/no AD copathology (SYN-AD = 35). Digital measures of tau, β-amyloid (Aβ), and SYN histopathology in neocortical and subcortical/limbic regions were compared between groups and related to antemortem cognitive testing. RESULTS: SYN burden was higher in SYN + AD than SYN-AD in each neocortical region (F1, 54 = 5.6-6.0, p < 0.02) but was equivalent in entorhinal cortex and putamen (F1, 43-49 = 0.7-1.7, p > 0.2). SYN + AD performed worse than SYN-AD on a temporal lobe-mediated naming task (t27 = 2.1, p = 0.04). Antemortem cognitive test scores inversely correlated with tau burden (r = -0.39 to -0.68, p < 0.05). AD had higher tau than SYN + AD in all regions (F1, 43 = 12.8-97.2, p < 0.001); however, SYN + AD had a greater proportion of tau in the temporal neocortex than AD (t41 = 2.0, p < 0.05), whereas AD had a greater proportion of tau in the frontal neocortex than SYN + AD (t41 = 3.3, p < 0.002). SYN + AD had similar severity and distribution of neocortical Aβ compared to AD (F1, 40-43 = 1.6-2.0, p > 0.1). INTERPRETATION: LBD patients with AD copathology harbor greater neocortical SYN pathology. Regional tau pathology relates to cognitive performance in LBD dementia, and its distribution may diverge from pure AD. Tau copathology contributes uniquely to the heterogeneity of cognitive impairment in LBD. Ann Neurol 2018; 1-13 ANN NEUROL 2019;85:259-271.
引用
- Coughlin D, Xie SX, Liang M, et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Ann Neurol. 2019. PMID: 30549331. doi:10.1002/ana.25392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。